Drug Development

Articles

Company and People Notes: Cambridge Major Labs acquires ChemShop; Helix BioPharma restructures senior positions, more.

Company and People Notes: Cambridge Major Labs Acquires ChemShop; Helix BioPharma Restructures Senior Positions, More

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Growth in the global pharmaceutical industry is expected to slow in 2008, marked by slowing growth in the United States and other major markets. At the same time, pharmaceutical industry growth in emerging markets is expected to reach double-digits, although these markets still represent a small percentage of global pharmaceutical sales.

Global Pharmaceutical Industry Growth to Slow in 2008

The US Government Accountability Office issued findings that are largely critical of the US Food and Drug Administration in managing its inspections of foreign drug-manufacturing facilities.

GAO Criticizes FDA’s Foreign-Drug Inspection Process

The Bulk Pharmaceuticals Task Force, an affiliate of the Synthetic Organic Chemical Manufacturers Association (SOCMA) weighed in on the Congressional debate concerning the US Food and Drug Administration?s inspection process of foreign drug- manufacturing facilities.

SOCMA Offers Recommendations To Better Foreign Inspection Process

Company and People Notes: BASF raises prices on excipients; Verus Pharmaceuticals appoints president and CEO; more.

Company and People Notes: BASF Raises Prices on Excipients; Verus Pharmaceuticals Appoints President and CEO; More

Pfizer's Lipitor patent revoked in Germany, promotions at Charles River Labs, more.

Company and People Notes: Pfizer's Lipitor Patent Revoked in Germany, Promotions at Charles River Labs, More

US Food and Drug Administration Commissioner Andrew C. von Eschenbach testified before Congress last week to outline the agency’s inspection process for foreign drug manufacturers and efforts to improve the agency’s information technology systems.

FDA Commissioner Testifies Before Congress on Foreign Inspection Process

The US Food and Drug Administration’s effectiveness in regulating the manufacture of pharmaceutical products and active pharmaceutical ingredients at foreign facilities was questioned at a Congressional hearing last week. Congress, industry, and government officials weighed in on the issue.

Congress Focuses on FDA Inspections of Foreign Drug Facilities

Recent activity among contract manufacturing organizations include expansions for Lonza and Codexis in Asia and the addition of aseptic cytotoxic capabilities for DSM. Also, Vetter adds anticounterfeiting capabilities for prefilled syringes.

CMOs roll out expansions

Ash Stevens is adding cryogenic capabilities as part of an overall strategy to focus on small molecules requiring smaller volumes and complex chemistry.

Ingredients